MPM BioVentures IV QP LP

Insider CIK 1358309 · CHMA 10% owner · CNAT 10% owner · SNDX 10% owner · PCRX · TRIV 10% owner · EPZM 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
SNDX Syndax Pharmaceuticals Inc	C Conversion deriv	2016-03-08	2016-03-09	312,085	—	$0	0	SEC↗
SNDX Syndax Pharmaceuticals Inc	C Conversion deriv	2016-03-08	2016-03-09	1,138,210	—	$0	0	SEC↗
SNDX Syndax Pharmaceuticals Inc	C Conversion deriv	2016-03-08	2016-03-09	718,396	—	$0	0	SEC↗
SNDX Syndax Pharmaceuticals Inc	C Conversion	2016-03-08	2016-03-09	718,396	—	$0	1,856,606	SEC↗
SNDX Syndax Pharmaceuticals Inc	C Conversion	2016-03-08	2016-03-09	1,138,210	—	$0	1,138,210	SEC↗
SNDX Syndax Pharmaceuticals Inc	C Conversion	2016-03-08	2016-03-09	312,085	—	$0	2,168,691	SEC↗
CHMA CHIASMA, INC	C Conversion deriv	2015-07-21	2015-07-21	95,225	—	$0	0	SEC↗
CHMA CHIASMA, INC	C Conversion deriv	2015-07-21	2015-07-21	13,000,000	—	$0	0	SEC↗
CHMA CHIASMA, INC	C Conversion deriv	2015-07-21	2015-07-21	22,721,988	—	$0	0	SEC↗
CHMA CHIASMA, INC	C Conversion deriv	2015-07-21	2015-07-21	16,066,669	—	$0	0	SEC↗
CHMA CHIASMA, INC	C Conversion	2015-07-21	2015-07-21	10,426	—	$0	10,426	SEC↗
CHMA CHIASMA, INC	C Conversion	2015-07-21	2015-07-21	2,488,171	—	$0	2,498,597	SEC↗
CHMA CHIASMA, INC	C Conversion	2015-07-21	2015-07-21	1,423,566	—	$0	5,681,544	SEC↗
CHMA CHIASMA, INC	C Conversion	2015-07-21	2015-07-21	1,759,381	—	$0	4,257,978	SEC↗
TRIV TriVascular Technologies,	C Conversion deriv	2014-04-22	2014-04-23	1,516,122	—	$0	0	SEC↗
TRIV TriVascular Technologies,	C Conversion deriv	2014-04-22	2014-04-23	15,400,411	—	$0	0	SEC↗
TRIV TriVascular Technologies,	C Conversion deriv	2014-04-22	2014-04-23	37,369	—	$0	37,369	SEC↗
TRIV TriVascular Technologies,	C Conversion deriv	2014-04-22	2014-04-23	20,757,635	—	$0	0	SEC↗
TRIV TriVascular Technologies,	C Conversion deriv	2014-04-22	2014-04-23	6,000,000	—	$0	0	SEC↗
TRIV TriVascular Technologies,	C Conversion deriv	2014-04-22	2014-04-23	10,266,940	—	$0	0	SEC↗
TRIV TriVascular Technologies,	C Conversion deriv	2014-04-22	2014-04-23	2,947,605	—	$0	0	SEC↗
TRIV TriVascular Technologies,	C Conversion	2014-04-22	2014-04-23	114,942	—	$0	1,144,027	SEC↗
TRIV TriVascular Technologies,	C Conversion	2014-04-22	2014-04-23	230,756	—	$0	1,029,085	SEC↗
TRIV TriVascular Technologies,	C Conversion	2014-04-22	2014-04-23	798,329	—	$0	798,329	SEC↗
TRIV TriVascular Technologies,	C Conversion	2014-04-22	2014-04-23	253,066	—	$0	1,776,692	SEC↗
TRIV TriVascular Technologies,	C Conversion	2014-04-22	2014-04-23	379,599	—	$0	1,523,626	SEC↗
EPZM Epizyme, Inc.	S Sale	2014-02-10	2014-02-11	466,666	$29.25	$13.65M	2,413,819	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	8,333,334	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	265,837	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	32,220	—	$0	32,220	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion	2013-07-30	2013-08-01	1,010,099	—	$0	1,010,099	SEC↗
CNAT Conatus Pharmaceuticals In	P Buy	2013-07-30	2013-08-01	165,265	$11.00	$1.82M	1,192,080	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2013-07-30	2013-08-01	16,716	$11.00	$183.9K	1,026,815	SEC↗
EPZM Epizyme, Inc.	C Conversion deriv	2013-06-05	2013-06-06	1,176,472	—	$0	0	SEC↗
EPZM Epizyme, Inc.	C Conversion deriv	2013-06-05	2013-06-06	6,930,000	—	$0	0	SEC↗
EPZM Epizyme, Inc.	C Conversion	2013-06-05	2013-06-06	2,309,998	—	$0	2,488,329	SEC↗
EPZM Epizyme, Inc.	C Conversion	2013-06-05	2013-06-06	392,156	—	$0	2,880,485	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2013-03-11	2013-03-13	500,000	$27.86	$13.93M	2,790,479	SEC↗